R. Mukherjee

发表

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.

H. White, P. Théroux, S. Borzak, 2002, American heart journal.

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.

H. White, M. Gheorghiade, H. Krum, 2005, Journal of the American College of Cardiology.

A pilot study of rhuIL‐11 treatment of refractory ITP

J. Bussel, A. Stone, R. Mukherjee, 2001, American journal of hematology.

353 Eplerenone benefit at 30 days in high‐risk subgroups in the EPHESUS trial

D. J. Veldhuisen, H. Krum, B. Pitt, 2005 .

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

M. Pfeffer, R. Califf, J. Rouleau, 2004, JAMA.

Combination Angiotensin Receptor Blocker/Hydrochlorothiazide as Initial Therapy in the Treatment of Patients With Severe Hypertension

A. Gradman, L. Demopoulos, R. Mukherjee, 2004, Journal of clinical hypertension.

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.

R. Patni, M. Epstein, A. Lewin, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study☆☆☆★

H. White, P. Théroux, S. Borzak, 2002 .

The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.

M. Gheorghiade, H. Krum, B. Pitt, 2009, American heart journal.

Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction

B. Pitt, B. Greenberg, A. Feldman, 2010, Circulation. Heart failure.

Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)

L. Ruilope, G. Bakris, B. Pitt, 2008, Circulation.

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction ≤30%

A. Parkhomenko, Jeffrey L. Anderson, D. J. Veldhuisen, 2006, European journal of heart failure.